Mechanisms of Stress (Takotsubo) Cardiomyopathy

Heart Failure Clinics

Volumn 9, Issue 2, 2013, Pages 197-205

  Szardien, Sebastian ^a   Möllmann, Helge ^a,b   Willmer, Matthias ^a   Akashi, Yoshihiro J ^c   Hamm, Christian W ^a,b   Nef, Holger M ^a,b  

^a Kerckhoff Heart and Thorax Center ^*  (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Catecholamines; Contractile dysfunction; Stress cardiomyopathy; Takotsubo cardiomyopathy

Indexed keywords

CALCIUM; CATECHOLAMINE; SEX HORMONE;

CALCIUM HOMEOSTASIS; ELECTRON MICROSCOPY; HEART INFARCTION; HUMAN; IMMUNOHISTOCHEMISTRY; MICROCIRCULATION; NONHUMAN; PATHOPHYSIOLOGY; POSTMENOPAUSE; PREVALENCE; REVIEW; TAKOTSUBO CARDIOMYOPATHY; WESTERN BLOTTING;

CATECHOLAMINES; FEMALE; HUMANS; TAKOTSUBO CARDIOMYOPATHY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84876806095     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2012.12.012     Document Type: Review

References (58)

1. Akashi Y.J., Nakazawa K., Sakakibara M., et al. The clinical features of takotsubo cardiomyopathy. QJM 2003, 96(8):563-573.
2. Dote K., Sato H., Tateishi H., et al. J Cardiol 1991, 21(2):203-214. [in Japanese].
3. Nef H.M., Mollmann H., Hamm C.W., et al. Herz 2006, 31(5):473-479. [in German].
4. Akashi Y.J., Nef H.M., Mollmann H., et al. Stress cardiomyopathy. Annu Rev Med 2010, 61:271-286.
5. Nef H.M., Mollmann H., Elsasser A. Tako-tsubo cardiomyopathy (apical ballooning). Heart 2007, 93(10):1309-1315.
6. Bybee K.A., Kara T., Prasad A., et al. Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med 2004, 141(11):858-865.
7. Gianni M., Dentali F., Grandi A.M., et al. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J 2006, 27(13):1523-1529.
8. Cacciotti L., Camastra G.S., Beni S., et al. A new variant of Tako-tsubo cardiomyopathy: transient mid-ventricular ballooning. J Cardiovasc Med (Hagerstown) 2007, 8(12):1052-1054.
9. Botto F., Trivi M., Padilla L.T. Transient left midventricular ballooning without apical involvement. Int J Cardiol 2008, 127(3):e158-e159.
10. Kurowski V., Kaiser A., von Hof K., et al. Apical and midventricular transient left ventricular dysfunction syndrome (tako-tsubo cardiomyopathy): frequency, mechanisms, and prognosis. Chest 2007, 132(3):809-816.
11. Nef H.M., Mollmann H., Kostin S., et al. Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J 2007, 28(20):2456-2464.
12. Elesber A.A., Prasad A., Bybee K.A., et al. Transient cardiac apical ballooning syndrome: prevalence and clinical implications of right ventricular involvement. J Am Coll Cardiol 2006, 47(5):1082-1083.
13. Donohue D., Movahed M.R. Clinical characteristics, demographics and prognosis of transient left ventricular apical ballooning syndrome. Heart Fail Rev 2005, 10(4):311-316.
14. Nef H.M., Mollmann H., Hilpert P., et al. Severe mitral regurgitation in Tako-Tsubo cardiomyopathy. Int J Cardiol 2009, 132(2):e77-e79.
15. Akashi Y.J., Tejima T., Sakurada H., et al. Left ventricular rupture associated with Takotsubo cardiomyopathy. Mayo Clin Proc 2004, 79(6):821-824.
16. Nef H.M., Mollmann H., Sperzel J., et al. Temporary third-degree atrioventricular block in a case of apical ballooning syndrome. Int J Cardiol 2006, 113(2):e33-e35.
17. Elesber A.A., Prasad A., Lennon R.J., et al. Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol 2007, 50(5):448-452.
18. Brinjikji W., El-Sayed A.M., Salka S. In-hospital mortality among patients with takotsubo cardiomyopathy: A study of the National Inpatient Sample 2008 to 2009. Am Heart J 2012, 164(2):215-221.
19. Burgdorf C., Kurowski V., Bonnemeier H., et al. Long-term prognosis of the transient left ventricular dysfunction syndrome (Tako-Tsubo cardiomyopathy): focus on malignancies. Eur J Heart Fail 2008, 10(10):1015-1019.
20. Abe Y., Kondo M., Matsuoka R., et al. Assessment of clinical features in transient left ventricular apical ballooning. J Am Coll Cardiol 2003, 41(5):737-742.
21. Kurisu S., Sato H., Kawagoe T., et al. Tako-tsubo-like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction. Am Heart J 2002, 143(3):448-455.
22. Pilgrim T.M., Wyss T.R. Takotsubo cardiomyopathy or transient left ventricular apical ballooning syndrome: a systematic review. Int J Cardiol 2008, 124(3):283-292.
23. Merli E., Sutcliffe S., Gori M., et al. Tako-Tsubo cardiomyopathy: new insights into the possible underlying pathophysiology. Eur J Echocardiogr 2006, 7(1):53-61.
24. Brunetti N.D., Ieva R., Rossi G., et al. Ventricular outflow tract obstruction, systolic anterior motion and acute mitral regurgitation in Tako-Tsubo syndrome. Int J Cardiol 2008, 127(3):e152-e157.
25. Barriales Villa R., Bilbao Quesada R., Iglesias Rio E., et al. Rev Esp Cardiol 2004, 57(1):85-88. [in Spanish].
26. Desmet W. Dynamic LV obstruction in apical ballooning syndrome: the chicken or the egg. Eur J Echocardiogr 2006, 7(1):1-4.
27. Fineschi V., Michalodimitrakis M., D'Errico S., et al. Insight into stress-induced cardiomyopathy and sudden cardiac death due to stress. A forensic cardio-pathologist point of view. Forensic Sci Int 2010, 194(1-3):1-8.
28. Nef H.M., Mollmann H., Troidl C., et al. Expression profiling of cardiac genes in Tako-Tsubo cardiomyopathy: insight into a new cardiac entity. J Mol Cell Cardiol 2008, 44(2):395-404.
29. Yoshida T., Hibino T., Kako N., et al. A pathophysiologic study of tako-tsubo cardiomyopathy with F-18 fluorodeoxyglucose positron emission tomography. Eur Heart J 2007, 28(21):2598-2604.
30. Elesber A., Lerman A., Bybee K.A., et al. Myocardial perfusion in apical ballooning syndrome correlate of myocardial injury. Am Heart J 2006, 152(3). 469.e9-13.
31. Kume T., Akasaka T., Kawamoto T., et al. J Cardiol 2004, 43(3):123-129. [in Japanese].
32. Sharkey S.W. Electrocardiogram mimics of acute ST-segment elevation myocardial infarction: insights from cardiac magnetic resonance imaging in patients with tako-tsubo (stress) cardiomyopathy. J Electrocardiol 2008, 41(6):621-625.
33. MacLennan D.H., Asahi M., Tupling A.R. The regulation of SERCA-type pumps by phospholamban and sarcolipin. Ann N Y Acad Sci 2003, 986:472-480.
34. Asahi M., Sugita Y., Kurzydlowski K., et al. Sarcolipin regulates sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) by binding to transmembrane helices alone or in association with phospholamban. Proc Natl Acad Sci U S A 2003, 100(9):5040-5045.
35. Nef H.M., Mollmann H., Troidl C., et al. Abnormalities in intracellular Ca2+ regulation contribute to the pathomechanism of Tako-Tsubo cardiomyopathy. Eur Heart J 2009, 30(17):2155-2164.
36. James P., Inui M., Tada M., et al. Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum. Nature 1989, 342(6245):90-92.
37. Wittstein I.S., Thiemann D.R., Lima J.A., et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005, 352(6):539-548.
38. Kume T., Kawamoto T., Okura H., et al. Local release of catecholamines from the hearts of patients with tako-tsubo-like left ventricular dysfunction. Circ J 2008, 72(1):106-108.
39. Lefer D.J., Granger D.N. Oxidative stress and cardiac disease. Am J Med 2000, 109(4):315-323.
40. Bolli R. Mechanism of myocardial "stunning". Circulation 1990, 82(3):723-738.
41. Kobayashi A., Kang M.I., Watai Y., et al. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol 2006, 26(1):221-229.
42. Xu Q., Dalic A., Fang L., et al. Myocardial oxidative stress contributes to transgenic beta(2)-adrenoceptor activation-induced cardiomyopathy and heart failure. Br J Pharmacol 2011, 162(5):1012-1028.
43. Zhang G.X., Kimura S., Nishiyama A., et al. Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovasc Res 2005, 65(1):230-238.
44. Ueyama T., Kawabe T., Hano T., et al. Upregulation of heme oxygenase-1 in an animal model of Takotsubo cardiomyopathy. Circ J 2009, 73(6):1141-1146.
45. Lyon A.R., Rees P.S., Prasad S., et al. Stress (Takotsubo) cardiomyopathy-a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. Nat Clin Pract Cardiovasc Med 2008, 5(1):22-29.
46. Paur H., Wright P.T., Sikkel M.B., et al. High levels of circulating epinephrine trigger apical cardiodepression in a beta2-Adrenoceptor/Gi-dependent manner: a new model of takotsubo cardiomyopathy. Circulation 2012, 126(6):697-706.
47. Gong H., Sun H., Koch W.J., et al. Specific beta(2)AR blocker ICI 118,551 actively decreases contraction through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heart. Circulation 2002, 105(21):2497-2503.
48. Mori H., Ishikawa S., Kojima S., et al. Increased responsiveness of left ventricular apical myocardium to adrenergic stimuli. Cardiovasc Res 1993, 27(2):192-198.
49. Paur H., Wright P.T., Sikkel M.B., et al. High Levels of Circulating Epinephrine Trigger Apical Cardiodepression in a beta2-Adrenergic Receptor/Gi-Dependent Manner: a New Model of Takotsubo Cardiomyopathy. Circulation 2012, 126(6):697-706.
50. Ueyama T., Kasamatsu K., Hano T., et al. Catecholamines and estrogen are involved in the pathogenesis of emotional stress-induced acute heart attack. Ann N Y Acad Sci 2008, 1148:479-485.
51. Sclarovsky S., Nikus K.C. The role of oestrogen in the pathophysiologic process of the Tako-Tsubo cardiomyopathy. Eur Heart J 2010, 31(3):377. [author reply: 377-8].
52. Sclarovsky S., Nikus K. The electrocardiographic paradox of tako-tsubo cardiomyopathy-comparison with acute ischemic syndromes and consideration of molecular biology and electrophysiology to understand the electrical-mechanical mismatching. J Electrocardiol 2010, 43(2):173-176.
53. Ueyama T., Hano T., Kasamatsu K., et al. Estrogen attenuates the emotional stress-induced cardiac responses in the animal model of Tako-tsubo (Ampulla) cardiomyopathy. J Cardiovasc Pharmacol 2003, 42(Suppl 1):S117-S119.
54. Kam K.W., Qi J.S., Chen M., et al. Estrogen reduces cardiac injury and expression of beta1-adrenoceptor upon ischemic insult in the rat heart. J Pharmacol Exp Ther 2004, 309(1):8-15.
55. Wu M., Han M., Li J., et al. 17beta-estradiol inhibits angiotensin II-induced cardiac myofibroblast differentiation. Eur J Pharmacol 2009, 616(1-3):155-159.
56. Eskin B.A., Snyder D.L., Roberts J., et al. Cardiac norepinephrine release: modulation by ovariectomy and estrogen. Exp Biol Med (Maywood) 2003, 228(2):194-199.
57. Grohe C., Kahlert S., Lobbert K., et al. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett 1997, 416(1):107-112.
58. Bupha-Intr T., Wattanapermpool J. Regulatory role of ovarian sex hormones in calcium uptake activity of cardiac sarcoplasmic reticulum. Am J Physiol Heart Circ Physiol 2006, 291(3):H1101-H1108.